| Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study A Varatharaj, N Thomas, MA Ellul, NWS Davies, TA Pollak, EL Tenorio, ... The Lancet Psychiatry 7 (10), 875-882, 2020 | 1511 | 2020 |
| Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome S Keddie, J Pakpoor, C Mousele, M Pipis, PM Machado, M Foster, ... Brain 144 (2), 682-693, 2021 | 309 | 2021 |
| Evaluation and improvement of the National Early Warning Score (NEWS2) for COVID-19: a multi-hospital study E Carr, R Bendayan, D Bean, M Stammers, W Wang, H Zhang, T Searle, ... BMC medicine 19 (1), 1-16, 2021 | 147 | 2021 |
| The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non … A Marson, G Burnside, R Appleton, D Smith, JP Leach, G Sills, ... The Lancet 397 (10282), 1375-1386, 2021 | 140 | 2021 |
| The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority … A Marson, G Burnside, R Appleton, D Smith, JP Leach, G Sills, ... The Lancet 397 (10282), 1363-1374, 2021 | 132 | 2021 |
| Human autoantibodies specific for the α1A calcium channel subunit reduce both P-type and Q-type calcium currents in cerebellar neurons A Pinto, S Gillard, F Moss, K Whyte, P Brust, M Williams, K Stauderman, ... Proceedings of the National Academy of Sciences 95 (14), 8328-8333, 1998 | 132 | 1998 |
| COVID-19-associated risks and effects in myasthenia gravis (CARE-MG) S Muppidi, JT Guptill, S Jacob, Y Li, ME Farrugia, AC Guidon, JO Tavee, ... The Lancet Neurology 19 (12), 970-971, 2020 | 112 | 2020 |
| Neurologic manifestations of the cryopyrin-associated periodic syndrome JL Kitley, HJ Lachmann, A Pinto, L Ginsberg Neurology 74 (16), 1267-1270, 2010 | 90 | 2010 |
| CNS inflammatory vasculopathy with antimyelin oligodendrocyte glycoprotein antibodies in COVID-19 AA Pinto, LS Carroll, V Nar, A Varatharaj, I Galea Neurology: Neuroimmunology & Neuroinflammation 7 (5), e813, 2020 | 71 | 2020 |
| Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry 7: 875–882 A Varatharaj, N Thomas, MA Ellul, NWS Davies, TA Pollak, EL Tenorio, ... S2215-0366 (20), 2020 | 60 | 2020 |
| Lyme disease: diagnosis and management ALR Russell, MS Dryden, AA Pinto, JK Lovett Practical neurology 18 (6), 455-464, 2018 | 59 | 2018 |
| Early and marked benefit with GPi DBS for Lubag syndrome presenting with rapidly progressive life‐threatening dystonia I Martinez‐Torres, P Limousin, S Tisch, R Page, A Pinto, T Foltynie, ... Movement disorders: official journal of the Movement Disorder Society 24 (11 …, 2009 | 56 | 2009 |
| The action of Lambert–Eaton myasthenic syndrome immunoglobulin G on cloned human voltage‐gated calcium channels A Pinto, K Iwasa, C Newland, J Newsom‐Davis, B Lang Muscle & Nerve: Official Journal of the American Association of …, 2002 | 52 | 2002 |
| Plasma exchange in neurological disease C Osman, R Jennings, K El-Ghariani, A Pinto Practical neurology 20 (2), 92-99, 2020 | 51 | 2020 |
| Pathogenic autoantibodies in the Lambert‐Eaton myasthenic syndrome B Lang, A Pinto, F Giovannini, J NEWSOM‐DAVIS, A Vincent Annals of the New York Academy of Sciences 998 (1), 187-195, 2003 | 49 | 2003 |
| Do pain, anxiety and depression influence quality of life for people with amyotrophic lateral sclerosis/motor neuron disease? A national study reconciling previous conflicting … R Edge, R Mills, A Tennant, PJ Diggle, CA Young, ... Journal of neurology 267, 607-615, 2020 | 45 | 2020 |
| The Role of Autoantibodies in Lambert‐Eaton Myasthenic Syndromeaa B Lang, S Waterman, A Pinto, D Jones, F Moss, J Boot, P Brust, ... Annals of the New York Academy of Sciences 841 (1), 596-605, 1998 | 39 | 1998 |
| Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective C Wong, M Stavrou, E Elliott, JM Gregory, N Leigh, AA Pinto, TL Williams, ... Brain communications 3 (4), fcab242, 2021 | 38 | 2021 |
| The relationships between symptoms, disability, perceived health and quality of life in amyotrophic lateral sclerosis/motor neuron disease CA Young, J Ealing, C McDermott, T Williams, A Al-Chalabi, T Majeed, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20 (5-6), 317-327, 2019 | 37 | 2019 |
| Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis B Singh, S Lant, S Cividini, JWS Cattrall, LC Goodwin, L Benjamin, ... PLoS One 17 (6), e0263595, 2022 | 33 | 2022 |
